Area of research
Epidemiology · Hepatology
Research interest
Research interests include HIV, Drug Use, Sexual Risk, Hepatitis C virus research, Substance Abuse Treatment and Outcomes, and Opioid Use Disorder Treatment.
The global epidemiology of injecting drug use, HIV, viral hepatitis and tuberculosis among people who are incarcerated: a multistage systematic review
Global coverage of interventions for reduction of injecting drug use-related harm, HIV, viral hepatitis and tuberculosis in prisons and other carceral settings: A systematic review
Dynamic shifts in crystal methamphetamine and heroin price and purity in metropolitan Melbourne and rural Victoria, Australia, 2009-2020.
Commentary on Dowd et al.: Beyond single data sources-Consistency checking and evidence synthesis for prevalence estimation.
Initiation, cessation and resumption of attendance at the Melbourne supervised injecting room among a cohort of people who inject drugs.
Staff perspectives on implementing opt-out blood-borne virus testing in English emergency departments: a qualitative study.
Estimating incidence rates of primary infection and reinfection with hepatitis C virus among people who inject drugs in Scotland: a model-based analysis of repeated cross-sectional survey data.
Optimal provision of opioid agonist therapy (OAT) and needle and syringe programmes (NSP): a realist evaluation.
Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysis.
Delivering Effective Hepatitis C Virus Treatment in an Embedded Primary Care Setting Within a Tertiary Care Hospital in Karachi, Pakistan.
Factors Associated With Opioid Agonist Treatment Engagement and Harm Reduction Service Use: Findings From the New South Wales Opioid Dependence Survey.
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modelling.
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis.
A qualitative study of benzodiazepine/z-drug and opioid co-use patterns and overdose risk.
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling study.
Association of volatile substance, nitrous oxide and alkyl nitrate use with mental health in UK adolescents.
Motivations underlying co-use of benzodiazepines and opioids in the UK: a qualitative study.
Quantifying the impact of a large-scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data-modeling study.
Modeling the Potential Health, Health Economic, and Health Inequality Impact of a Large-Scale Rollout of the Drink Less App in England.
Evaluating the effectiveness of the Drink Less smartphone app for reducing alcohol consumption compared with usual digital care: a comprehensive synopsis from a 6-month follow-up RCT.
Risk Factors for Hepatitis C Virus Among the General Population in Sub‐Saharan Africa—An Analysis of Systematic Review Data
Delineating trajectories of alcohol consumption and alcohol problems from adolescence to young adulthood: An integrated assessment of genetic, familial, and psychosocial factors.
Childhood conduct problems, potential snares in adolescence, and problematic substance use in Brazil.
Estimating Prevalence and Number of People With Chronic Hepatitis B: A Multiplier Method Based on Public Health Surveillance Data in UK (2015-2021).
Pilot postal birth cohort hepatitis C virus screening in UK primary care: HepCAPP study.
Identifying key risk factors for intentional self-harm, including suicide, among a cohort of people prescribed opioid agonist treatment: A predictive modelling study.
Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011-2020: A national retrospective cohort study.
Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals?
Characterising benzodiazepine use and the association with non-fatal overdose among people who inject opioids in England, Wales and Northern Ireland.
Risk prediction models for targeted testing of HIV, hepatitis B and hepatitis C: a systematic review and meta-analysis.